carbamates has been researched along with Erdheim-Chester Disease in 1 studies
Erdheim-Chester Disease: A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, F | 1 |
| Hiramoto, N | 1 |
| Yamashita, D | 1 |
| Hara, S | 1 |
| Furukawa, Y | 1 |
| Ishii, J | 1 |
| Nagata, K | 1 |
| Nannya, Y | 1 |
| Ogawa, S | 1 |
| Ishikawa, T | 1 |
1 other study available for carbamates and Erdheim-Chester Disease
| Article | Year |
|---|---|
Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAF
Topics: Aged, 80 and over; Carbamates; Erdheim-Chester Disease; Female; Humans; Mutation; Proto-Oncogene Pro | 2021 |